2019
DOI: 10.1016/j.yjmcc.2019.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Mir-455-3p-1 represses FGF7 expression to inhibit pulmonary arterial hypertension through inhibiting the RAS/ERK signaling pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
22
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(24 citation statements)
references
References 36 publications
2
22
0
Order By: Relevance
“…The mRNA level of FGF-7 was upregulated in tissues obtained from PAH patients and in PAH-PASMCs [88]. miR-455-3p-1 alleviated PAH by regulating FGF7 and RAS/ERK signaling, respectively [88]. In a recent study, there were decreased levels of miR-181a-5p and miR-181b-5p, whereas the protein level of endocan was elevated in monocrotaline-induced PAH in a time-dependent manner [89].…”
Section: Pahmentioning
confidence: 99%
See 1 more Smart Citation
“…The mRNA level of FGF-7 was upregulated in tissues obtained from PAH patients and in PAH-PASMCs [88]. miR-455-3p-1 alleviated PAH by regulating FGF7 and RAS/ERK signaling, respectively [88]. In a recent study, there were decreased levels of miR-181a-5p and miR-181b-5p, whereas the protein level of endocan was elevated in monocrotaline-induced PAH in a time-dependent manner [89].…”
Section: Pahmentioning
confidence: 99%
“…It was further explained that miR-205-5p regulated MICAL2, a protein that proliferated hPASMCs via the activation of ERK1/2 signaling [87]. The mRNA level of FGF-7 was upregulated in tissues obtained from PAH patients and in PAH-PASMCs [88]. miR-455-3p-1 alleviated PAH by regulating FGF7 and RAS/ERK signaling, respectively [88].…”
Section: Pahmentioning
confidence: 99%
“…The following genes showed similar expression patterns in both models: Pah , Fgf7 , Sptssb , Nd6 , Axdnd1 . Here, Pah 4 , 34 and Fgf7 33 have been previously implicated in hypertension, therefore further analysis of Sptssb , Nd6 , and Axdnd1 may help elucidate whether these genes contribute to development of hypertension. In fact, a full whole transcriptome profiling of the SHR adrenals will greatly contribute to this type of analysis.…”
Section: Discussionmentioning
confidence: 87%
“…1 e,f respectively, ranked based on fold change. Some of the DEGs have been previously associated with the development of hypertension, including Slc9A3 31 (solute carrier family 9 member A3; fold change = 4.55), Hpgd 32 (hydroxyprostaglandin dehydrogenase; fold change = 2.56), Pah 7 , 30 (phenylalanine hydroxylase; fold change = 2.10), Fgf7 33 (fibroblast growth factor 7; fold change = 2.05) and Cyp2e1 34 (cytochrome p450, family 2, subfamily e1; fold change = − 2.03) 7 , 34 , 35 . However, the majority of top dysregulated genes are currently not implicated in the development of hypertension.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation